Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals’ VALOR Trial Based on Periodic Safety Review – msnbc.com

The VALOR logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8774 About Vosaroxin Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), a class of compounds that has not been used previously for the treatment of cancer.